Q

uniQure NV
D

QURE

15.100
USD
-0.10
(-0.68%)
مغلق
حجم التداول
24,361
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
826,702,290
أصول ذات صلة
C
CLLS
0.49000
(24.38%)
2.50000 USD
C
CRSP
-1.350
(-2.04%)
64.760 USD
E
EDIT
-0.11000
(-3.38%)
3.14000 USD
F
FATE
-0.01000
(-0.80%)
1.23500 USD
N
NTLA
0.830
(6.50%)
13.595 USD
R
RCKT
-0.07500
(-2.33%)
3.14000 USD
S
SGMO
-0.01190
(-1.99%)
0.58600 USD
V
VYGR
-0.08000
(-2.41%)
3.23500 USD
المزيد
الأخبار المقالات

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.